Reducing the long-term impact of chronic disease on the lives of those affected is a major policy and research priority. 1 Longterm non-communicable diseases are a major threat to public health. They account for 60% of all deaths worldwide, with 80% of chronic-disease deaths occurring in lowand middle-income countries. In the next 10 years, China, India and the UK are projected to lose $558 billion, $237 billion and $33 billion, respectively, as a result of reduced economic productivity from heart disease, stroke and diabetes. 2 Diabetes provides an exemplar medical condition that illustrates many of the problems of dealing with such long-term conditions. The number of people with the condition will double in the next 20 years to over 300 million. 2 Complications of diabetes include kidney, heart and eye disease. Type 2 diabetes accounts for 85% of those with the disease and usually develops in mid-life. It is initially treated by changes in lifestyle, lowering blood glucose, reducing blood pressure and controlling lipids with tablets. Despite strong evidence that the development of the condition and its complications can be reduced, [3] [4] [5] health systems do not appear to consistently deliver treatments of known efficacy to patients, and these treatments do not always appear to be used by patients as recommended. One of the major challenges to health systems around the world is the need for a better understanding of the nature of these difficulties, in order to translate the promise of effective treatments into health benefits for patients.
Considerable progress has been made in understanding and overcoming the failure to make best use of medical treatments. There is increasing awareness of 'clinical inertia'. Clinicians may not recognize the need for initiating treatment, and subsequent necessary changes in treatment may not be carried out. However, increasing emphasis on performance-feedback to clinicians and provision of incentives to provide high quality care, can lead to substantial improvements in outcomes. 6, 7 Another area of progress has been to ensure that medication regimens are simplified. Once daily medication regimens lead to greater rates of adherence than multiple dose regimens. 8 A major development has been the recognition of a need for 'concordance', about the necessity for, and types of, treatment to be used, between clinician and patient. Alternative approaches, including a paternalistic recommendation of treatment may fail to adequately address concerns about taking medication. Emphasis on concordance leads to a consultation process in which the patients own experience of illness and response to treatment is considered in planning an agreed treatment plan. Involvement in decision making may lead to improvements in motivation and subsequent persistence with treatment. 9 Ensuring that doctors and nurses are able to provide clear information about diabetes and its treatment is one way to improve medication adherence among patients. The importance of clear provider-patient communication, particularly in the situation of inadequate health literacy, has been well-documented for diabetes patients. 10, 11 In the UK, a programme led by the Medicines Partnership was established by the Department of Health in 2002 and has promoted the concept of concordance -or shared decision-making -as an approach to help patients to get the most from their medicines.
Some of the problems taking medicines might arise because specific issues are not raised with patients, for example the need for continuing treatment. A recent study in Pakistan carefully measured the impact of a health programme to improve treatment of hypertension on the use of medicines. The programme focused on doctors and included training in how to listen to patients, respond to their concerns, and explain clearly how to take medications regularly. Training in hypertension management, emphasizing the need for communication, led to a 50% increase in adherence 12 and similar improvements have been observed for glycemic control in diabetes. 13 Despite excellent progress in some areas to improve use of medication, there remain gaps in our understanding of the circumstances in which medicines are not prescribed or used. Until recently, reliance on pharmacy dispensing data and lack of prescribing data, made it difficult to identify whether appropriate therapies were not being used by the patient or not being prescribed by the clinician. A missing record of a dispensed medicine could be due either to the doctor never prescribing a therapy, or to a prescription being written, but the patient never picking it up. Accurate assessment of the scale of non-adherence is facilitated by use of new prescribing databases. The DARTS collaboration, using linked prescribing databases in Tayside, found that less than a third of patients were dispensed their single hypoglycaemic sufficiently regularly to cover 90% of treatment days in 1 year. 14 A recent study using records from the Kaiser Permanente health system found that whilst 20% of patients with diabetes failed to fully adhere to their prescribed treatment as a whole, up to 70% of patients with risk factors above target had poor adherence or a lack of treatment intensification. 15 Studies across the world have shown consistent findings and highlight the need to identify and address the problems leading to non-adherence.
Another approach to understand why some patients do not take their medicines regularly is to monitor the way that tablets are taken. One strategy is the use of 'TrackCap' containers with lids concealing an electronic time-stamping microcircuit to check (with patient consent) how often the lid is removed from the container. A recent report has pooled data from a series of studies to systematically describe the way that tablets are missed: occasional days are omitted as the result of lapses of memory; tablets forgotten as people go on holiday; or whole weekends forgotten as routine changes. 16 However the potential for using this tool for precise measurement of the behaviour of taking medication is limited when used in groups of people who have adopted weekly pill dispensers and tablets are intermittently transferred to another container.
A number of randomized trials have been carried out to evaluate interventions to support patients in adhering to their treatment regimens, and they are summarized in a recent systematic review. 14, 17 Amongst the findings of the review was the observation that more complex interventions, involving elements of counselling, reminders, selfmonitoring and other forms of supervision, were more likely to be effective than trials not incorporating these elements. Studies to be reported shortly will have started to use elements of improved measurement of adherence with interventions based on detailed studies of reasons for medication non-adherence. 18 The Supported Adherence to Medication study 19 evaluated the combination of two interventions: (i) asking patients to take part in an interview about their concerns with taking diabetes medicines; and (ii) offering approaches to help regular medication taking become a habit. The extent to which these interventions are found to have effect will guide further work to explore whether spending time talking about concerns with taking medicines, or focusing on the habit of taking medicines, is the more effective part of the intervention.
Many people struggle to take more than one tablet a day. Patients with diabetes are sometimes faced with taking up to 10 tablets a day. Another way to overcome the problem of taking several tablets, is to combine several of the medicines into a single tablet. The concept of combining medicines for preventing cardiovascular disease into a singe tablet, known as the 'polypill', is currently being evaluated in a series of trials. If successful, many of the individual tablets taken by patients with diabetes could be replaced by a single tablet. 20, 21 However, extant research on differences in adherence between single versus multiple pills daily is mixed, and thus the value of combining pills in an attempt to improve adherence (weighed against the increased costs of such combination therapies) needs further study.
Greater understanding of the reasons why people find it difficult to take medication, as well as adopt healthier lifestyles, has led to a number of different strands of research. Some of this new knowledge is being drawn together into educational packages for patients with diabetes, and into training programmes to help health professionals be more aware of the problems. However, our understanding of the issues remains incomplete. Chronic Illness will be highlighting papers submitted on this topic in a special issue next year. If you have something to say in this area, then consider submitting your research article, review paper or methodological contribution for publication in this special issue. 
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